Understanding the Cognition and Decision Making of Community Anesthesiologists

Neuromuscular Blockade Clinical Trial

Official title:

Understanding the Cognition and Decision Making of Community Anesthesiologists in Their Management of End-of-case Neuromuscular Blockade: A Mixed Methods Study

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04195178
• Other study ID #: 181711
• Status: Recruiting
• Start date: August 3, 2023
• Est. completion date: June 2025

Study information

• Verified date: February 2024
• Source: Vanderbilt University Medical Center
• Contact: Matt Weinger, MD
• Phone: 615-936-6598
• Email: matt.weinger[@]vumc.org
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The investigators are interested in studying why experienced clinicians make specific decisions regarding the monitoring of patients' physiological states and why clinicians might make decisions that are contrary to current best practices or known evidence. More generally, the program objective is to refine and validate a novel methodology to delineate clinicians' decision-making strategies. More specifically, the investigators will study the decision to reverse neuromuscular blockade at the end of an anesthetic. This clinical decision will be studied in this project because: 1) it has been well documented that a substantial percentage of practitioners do not follow best practices; 2) the variables are relatively circumscribed and well described; and 3) it can be framed as a binary decision. The investigators propose to conduct an observational mixed-methods study developing and using clinical vignettes and cognitive interviews to better understand the decision-making approaches and preferences of clinically active anesthesia providers with regard to their decision-making during clinical anesthesia cases. After developing clinical vignettes and related questions, the investigators will first obtain detailed demographic and clinical practice variables from the participants via a survey. Participants will then review multiple vignettes that present different clinical situations that focus on decisions to reverse neuromuscular blockade and/or extubate the patient. Each participant will provide their decisions for each vignette. The investigators will then conduct an audiotaped interview, using cognitive task analysis methods, to ascertain the factors that played a role in these decisions.

Description:

The investigators propose to conduct a 3-site prospective observational mixed-methods study using clinical vignettes and cognitive interviews to better understand the decision making approaches and preferences of practicing community anesthesiologists with regard to the management of non-depolarizing neuromuscular blockade (NMB) at the end of general endotracheal anesthesia cases. The objectives of this initial study is to begin to understand: 1. When and why do community anesthesiologists choose to reverse NMB? 2. What are the decision preferences of community anesthesiologists with regard to their decisions to reverse NMB, and what are the clinician and clinical case factors that influence those decisions? 3. What are the operational knowledge gaps of anesthesia professionals with regard to their ability to follow best-practice evidence for the reversal of NMB? More generally, the program objective is to refine and validate a novel methodology to delineate clinicians' decision making strategies and triggers. 2.1.2. Study Hypotheses For this initial study, the investigators hypothesize that: 1. There will be a significant distribution of clinical variables across community anesthesiologists' decision to reverse NMB. 2. There will be measurable differences in participant demographics and practice attributes between those who closely follow evidence-based expectations for reversal of NMB and those who do not. The investigators expect community practitioners who do not reverse NMB in accordance with current best evidence to be older, to not be fellowship trained or subspecialty certified, and to practice in lower acuity settings. This will be a remotely conducted national prospective observational simulation study of 36 experienced community anesthesiologists using a clinical vignette and cognitive interviews to better understand the decision making approaches and preferences of practicing community anesthesiologists with regard to the management of neuromuscular blockade (NMB) at the end of general endotracheal anesthesia cases. Cognitive interview transcript coders and analysts will be blinded to the identity and attributes of the participants.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 36
• Est. completion date: June 2025
• Est. primary completion date: December 2024
• Gender: All
• Age group: 21 Years to 80 Years

Eligibility

Inclusion Criteria:

• Clinically active experienced anesthesia providers

Exclusion Criteria:

• Anesthesia providers who are no longer practicing or clinically active

Related Conditions & MeSH terms

• Neuromuscular Blockade

Locations

Country	Name	City	State
United States	Vanderbilt University Medical Center	Nashville	Tennessee

Sponsors (3)

Lead Sponsor	Collaborator
Vanderbilt University Medical Center	The Cooper Health System, University of Pittsburgh

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Average Decision Thresholds: Pharmacological measure of neuromuscular blocking drug effect	The average decision threshold is the average across all participant's decision threshold for this measure. The decision threshold is calculated by sequentially varying values of the pharmacological variables (i.e., doses and timing) within the context of a clinical scenario. Each participant's decision threshold is the equivalent of an ED50 or a MAC value (i.e., the equipoise point for their clinical decision based on that variable).	10 minutes
Primary	Average Decision Thresholds: Muscle strength	The average decision threshold is the average across all participant's decision threshold for this measure. The decision threshold is calculated by sequentially varying values of muscle strength within the context of a clinical scenario. Each participant's decision threshold is the equivalent of an ED50 or a MAC value (i.e., the equipoise point for their clinical decision based on that variable).	10 minutes
Primary	Average Decision Thresholds: Respiratory parameters	The average decision threshold is the average across all participant's decision threshold for this measure. The decision threshold is calculated by sequentially varying values of the respiratory parameters (i.e., variables contributing to minute ventilation) within the context of a clinical scenario. Each participant's decision threshold is the equivalent of an ED50 or a MAC value (i.e., the equipoise point for their clinical decision based on that variable).	10 minutes